Tag: neurovascular

CereVasc eShunt system

CereVasc gains financing to support eShunt system to treat hydrocephalus

CereVasc, a company focused on the treatment of patients with hydrocephalus, announced the closing of an expanded Series A financing that raised US$43.9 million....
021 Contour Cerus endovascular

Cerus Endovascular’s 021 Contour neurovascular system approved in Europe

Cerus Endovascular has received CE Mark approval for its 0.021-inch Contour neurovascular system, compatible with smaller commercially available 021 microcatheters for the treatment of...

Enrolment completed early for Rapid Medical’s TIGER study for thrombectomy device

Rapid Medical has announced that it has completed enrolment in the TIGER (Treatment with Intent to generate reperfusion) study ahead of the planned scheduled....
diffusion pharmaceuticals

Diffusion Pharmaceuticals anticipates coronavirus will slow enrolment in its ambulance-based stroke...

Diffusion Pharmaceuticals has announced that it expect delays in enrolment in the company’s ambulance-based PHAST-TSC phase 2 clinical trial in acute stroke due to...
Artio Medical study

Artio Medical announces interim study results highlighting aneurysm occlusion device

Artio Medical has announced the recent presentation of interim nonclinical study results at the ABC-WIN Seminar in Val d'Isere, France. Presented by Blaise Baxter,...
cerus endovascular contour

Cerus Endovascular receives CE mark approval for its Contour Neurovascular System...

Cerus Endovascular has received CE mark approval for its lead product, the Contour Neurovascular System, for the treatment of intracranial aneurysms. The system incorporates...
imperative care financing series C

Imperative Care announces appointment of Brian Armijo as vice president of...

Imperative Care has announced that Brian Armijo has been appointed as vice president of operations. With more than 25 years of manufacturing and operations...
CorPath GRX Corindus

Corindus announces regulatory approval of CorPath GRX for neurovascular intervention in...

Corindus Vascular Robotics has announced that it received approval from the Australian Therapeutic Goods Administration to commercialise its CorPath GRX System for neurovascular interventions...

Vesalio reports expansion of international distributor network and Stroke Congress Exhibition...

Vesalio has announced that it has executed multiple exclusive distribution agreements in Europe, Latin America, Asia and the Middle East and now has market...

Physicians’ Education Resource to host first annual International Congress on the...

Physicians’ Education Resource (PER), a worldwide leading resource for continuing medical education (CME), will host the first annual International Congress on the Future of...

Corindus announces FDA submission for neurovascular intervention indication for CorPath GRX

Corindus Vascular Robotics announces that it is seeking premarket clearance from the US Food and Drug Administration (FDA) to use the CorPath GRX System...

Are drug-coated balloons and drug-eluting stents the future in intracranial atherosclerotic...

Alternative treatment options for patients with intracranial atherosclerotic disease (ICAD) are needed, given its prevalence worldwide and the associated risk of recurrent ischaemic events....

Favourable revascularisation rates for first-in-man results of the Versi Retriever in...

First-in-man results of the Versi Retriever (NeuroVasc Technologies) in acute ischaemic stroke patients with large vessel occlusions demonstrate a promising safety profile and efficacious...

Cerenovus launches largest global registry to study stroke-inducing blood clots removed...

Johnson & Johnson has announced that its Cerenovus business has launched the single largest global registry, the EXCELLENT Registry, to collect and analyse stroke-inducing...